WuXi Biologics issues shares, repurchases stock for cancellation

As of September 5, 2025, WuXi Biologics (Cayman) Inc. reported an opening balance of 4,080,896,256 issued shares. On September 8, 2025, the company issued 57,500 new ordinary shares at HK$1.53 each, representing 0.00141% of the existing issued shares. This issuance was primarily for the exercise of share options under its Pre-IPO Share Option Scheme. Additionally, 6,000,000 ordinary shares were issued at HK$1.29 each for share option exercises, constituting 0.14703% of the existing shares. These transactions brought the closing balance of issued shares to 4,086,953,756 as of September 8, 2025.

In parallel, the company disclosed significant share repurchases intended for cancellation. On July 8, 2025, 11,680,000 shares were repurchased at HK$25.6 each, representing 0.28621% of the shares. A subsequent repurchase occurred on July 9, 2025, involving 11,500,000 shares at HK$25.91 each, accounting for 0.2818% of the shares. These repurchased shares have not yet been cancelled as of the reporting date.